Website URL: http://tinyurl.com/dy2gf6h
The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of ailments involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study included approximately 800 elderly men with low testosterone and symptoms associated with this affliction, like http://tinyurl.com/dy2gf6h sexual and physical dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.
The recent conflicting findings on testosterone therapy prompted Patel and his team to run a big systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among men. An estimated 13 million men in the USA have problems with low testosterone, which happens when the body does not make enough hormones because of a problem with the testicles or pituitary gland. This explains decline of energy, clear aging and an individual's unexpected weight gain.
No clear lower limit of testosterone has been established; yet 15 ng per dL (0.5 nmol per L) typically is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had noticeably decreased sexual desire in all situations and absent or markedly reduced climaxes. As a result of studies similar to this, supplemented with anecdotal evidence, many girls are started on testosterone therapy. Most girls can expect to spend one third of their lives in the postmenopausal period. Depression, anger, moodiness, insomnia, and lack of well being are common criticisms of postmenopausal women.